SCHEMBL31346106

SCHEMBL31346106

Cc1cc2oc(-c3cccc(Br)c3)cc2cc1F

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 8/20 0.63
▸ MAOA P21397 2/20 0.57
▸ GABRP O00591 5/20 0.48
▸ GABRD O14764 5/20 0.48
▸ GABRA1 P14867 5/20 0.48
▸ GABRB1 P18505 5/20 0.48
▸ GABRG2 P18507 5/20 0.48
▸ GABRB3 P28472 5/20 0.48
▸ GABRA5 P31644 5/20 0.48
▸ GABRA3 P34903 5/20 0.48
▸ GABRA2 P47869 5/20 0.48
▸ GABRB2 P47870 5/20 0.48
▸ GABRA4 P48169 5/20 0.48
▸ GABRE P78334 5/20 0.48
▸ GABRA6 Q16445 5/20 0.48
▸ GABRG1 Q8N1C3 5/20 0.48
▸ GABRG3 Q99928 5/20 0.48
▸ GABRQ Q9UN88 5/20 0.48
▸ TP53 P04637 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31346192 0.88 MAOB (0.64) MAOBMAOAGABRPGABRDGABRA1
SCHEMBL31346034 0.83 MAOB (0.57) MAOBMAOAGABRPGABRDGABRA1
SCHEMBL31346010 0.83 MAOB (0.63) MAOBMAOAGABRPGABRDGABRA1
SCHEMBL31345976 0.80 MAOB (0.57) MAOBMAOAGABRPGABRDGABRA1
SCHEMBL3031109 0.73 MAOB (1.00) MAOBMAOAGABRPGABRDGABRA1
SCHEMBL31346189 0.69 MAOB (0.69) MAOBMAOAGABRPGABRDGABRA1
SCHEMBL5546622 0.66 MAOB (0.54) MAOBMAOAGABRPGABRDGABRA1
SCHEMBL12369503 0.66 MAOB (0.69) MAOBMAOAGABRPGABRDGABRA1
SCHEMBL10173767 0.66 MAOB (0.56) MAOBMAOAGABRPGABRDGABRA1
SCHEMBL3980317 0.65 MAOB (0.66) MAOBMAOAGABRPGABRDGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4712967-A2 G-PROTEIN COUPLED RECEPTOR ANTAGONIST Enveda Therapeutics, Inc. (US) 2026-03-25 — — EP disclosed
WO-2024239000-A2 G-PROTEIN COUPLED RECEPTOR ANTAGONIST ENVEDA THERAPEUTICS, INC. (US) 2024-11-21 — — WO disclosed
Send feedback